AU2001267887A1 - Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components - Google Patents
Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the componentsInfo
- Publication number
- AU2001267887A1 AU2001267887A1 AU2001267887A AU2001267887A AU2001267887A1 AU 2001267887 A1 AU2001267887 A1 AU 2001267887A1 AU 2001267887 A AU2001267887 A AU 2001267887A AU 2001267887 A AU2001267887 A AU 2001267887A AU 2001267887 A1 AU2001267887 A1 AU 2001267887A1
- Authority
- AU
- Australia
- Prior art keywords
- components
- medicinal
- parathyroid hormone
- nasal administration
- administration containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101000032483 PTH Proteins 0.000 title 1
- 102000036364 human PTH protein Human genes 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-237718 | 2000-06-30 | ||
JP2000237718 | 2000-06-30 | ||
JP2000237717 | 2000-06-30 | ||
JP2000-237717 | 2000-06-30 | ||
PCT/JP2001/005674 WO2002002136A1 (en) | 2000-06-30 | 2001-06-29 | Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001267887A1 true AU2001267887A1 (en) | 2002-04-11 |
AU2001267887B2 AU2001267887B2 (en) | 2007-02-15 |
Family
ID=26597441
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU6788701A Pending AU6788701A (en) | 2000-06-30 | 2001-06-29 | Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
AU2001267887A Ceased AU2001267887B2 (en) | 2000-06-30 | 2001-06-29 | Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU6788701A Pending AU6788701A (en) | 2000-06-30 | 2001-06-29 | Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
Country Status (16)
Country | Link |
---|---|
US (1) | US7087248B2 (en) |
EP (1) | EP1297842A4 (en) |
KR (1) | KR20030016315A (en) |
CN (1) | CN100518819C (en) |
AR (1) | AR032461A1 (en) |
AU (2) | AU6788701A (en) |
BR (1) | BR0112381A (en) |
CA (1) | CA2414966A1 (en) |
IL (1) | IL153678A0 (en) |
MX (1) | MXPA02012947A (en) |
MY (1) | MY136546A (en) |
NO (1) | NO325831B1 (en) |
NZ (1) | NZ523457A (en) |
RU (1) | RU2292219C2 (en) |
TW (1) | TWI293563B (en) |
WO (1) | WO2002002136A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004075913A1 (en) * | 2003-02-28 | 2004-09-10 | Chugai Seiyaku Kabushiki Kaisha | Stabilized preparation containing protein |
EP1779864A4 (en) * | 2004-07-14 | 2010-10-20 | Chugai Pharmaceutical Co Ltd | Pth-containing preparation for transmucosal administration |
EP1945245A2 (en) * | 2005-11-10 | 2008-07-23 | The Board of Control of Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
EP1961765A1 (en) * | 2006-12-08 | 2008-08-27 | Zealand Pharma A/S | Truncated PTH peptides with a cyclic conformation |
KR200449313Y1 (en) * | 2008-02-18 | 2010-06-30 | 손복만 | The agriculture waterway having the drain valve |
JP2011001317A (en) * | 2009-06-19 | 2011-01-06 | Fumakilla Ltd | Cleaning agent for nose |
EP2682125B1 (en) | 2009-09-09 | 2020-11-04 | Asahi Kasei Pharma Corporation | Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 200 units |
KR101686271B1 (en) | 2009-11-18 | 2016-12-13 | 아사히 가세이 파마 가부시키가이샤 | Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans |
AU2009356227A1 (en) | 2009-12-07 | 2012-06-21 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
EP2471554A1 (en) * | 2010-12-28 | 2012-07-04 | Hexal AG | Pharmaceutical formulation comprising a biopharmaceutical drug |
CN104645318B (en) * | 2011-06-07 | 2021-11-02 | 旭化成制药株式会社 | High-purity freeze-dried preparation containing PTH and process for producing the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4086196A (en) * | 1975-03-28 | 1978-04-25 | Armour Pharmaceutical Company | Parathyroid hormone |
JP2505812B2 (en) * | 1987-07-10 | 1996-06-12 | 旭化成工業株式会社 | Freeze-dried composition of h-PTH (1-34) |
GB9020544D0 (en) | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5208041A (en) | 1991-05-23 | 1993-05-04 | Allelix Biopharmaceuticals Inc. | Essentially pure human parathyroid hormone |
JPH05271279A (en) * | 1991-08-07 | 1993-10-19 | Takeda Chem Ind Ltd | Human parathyroid hormone mutein and its production |
US5977070A (en) * | 1992-07-14 | 1999-11-02 | Piazza; Christin Teresa | Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
DE19538687A1 (en) | 1995-10-17 | 1997-04-24 | Boehringer Mannheim Gmbh | Stable pharmaceutical dosage forms containing parathyroid hormone |
-
2001
- 2001-06-29 CA CA002414966A patent/CA2414966A1/en not_active Abandoned
- 2001-06-29 AU AU6788701A patent/AU6788701A/en active Pending
- 2001-06-29 MX MXPA02012947A patent/MXPA02012947A/en active IP Right Grant
- 2001-06-29 KR KR1020027017881A patent/KR20030016315A/en not_active Application Discontinuation
- 2001-06-29 RU RU2003102629/15A patent/RU2292219C2/en not_active IP Right Cessation
- 2001-06-29 EP EP01945732A patent/EP1297842A4/en not_active Withdrawn
- 2001-06-29 MY MYPI20013133A patent/MY136546A/en unknown
- 2001-06-29 BR BR0112381-5A patent/BR0112381A/en not_active Application Discontinuation
- 2001-06-29 US US10/312,726 patent/US7087248B2/en not_active Expired - Fee Related
- 2001-06-29 IL IL15367801A patent/IL153678A0/en unknown
- 2001-06-29 NZ NZ523457A patent/NZ523457A/en not_active IP Right Cessation
- 2001-06-29 TW TW090116031A patent/TWI293563B/en not_active IP Right Cessation
- 2001-06-29 AR ARP010103122A patent/AR032461A1/en unknown
- 2001-06-29 WO PCT/JP2001/005674 patent/WO2002002136A1/en active IP Right Grant
- 2001-06-29 CN CNB018120636A patent/CN100518819C/en not_active Expired - Fee Related
- 2001-06-29 AU AU2001267887A patent/AU2001267887B2/en not_active Ceased
-
2002
- 2002-12-17 NO NO20026055A patent/NO325831B1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1385494T1 (en) | Compositions containing formoterol and a steroid for delivery into the lungs | |
HUP0101293A3 (en) | Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use | |
IL145983A0 (en) | Pharmaceutical composition for dermal use, comprising a corticosteroid and a vitamin d or an analogue thereof | |
HUP0104579A3 (en) | Glp-1 analogues, pharmaceutical compositions comprising thereof and their use | |
AU2001283563A1 (en) | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent | |
HK1061037A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
IL152024A0 (en) | Pharmaceutical compositions containing thyroid hormone and processes for the manufacture thereof | |
AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU2001290257A2 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
IL127572A (en) | Pharmaceutical composition and medicament for nasal administration | |
AU1131102A (en) | Medicinal aerosol formulations | |
HUP0202862A3 (en) | Pharmaceutical composition containing novel combination of loteprednol and antihistamines | |
AU2001267887A1 (en) | Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components | |
HUP0400120A3 (en) | Pharmaceutical composition for orally administering parathyroid hormone and calcitonin | |
AU6788701A (en) | Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components | |
AU2001258550A1 (en) | Insulin formulation for inhalation | |
IL160886A0 (en) | Nicotine containing pharmaceutical formulations and use thereof | |
AU2001274236A1 (en) | Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrinantagonist | |
GB0201607D0 (en) | Formulation for the administration of medicinal substances | |
HUP0400440A2 (en) | Pharmaceutical composition for nasal delivery of estradiol and norethisterone | |
AU2002336141A1 (en) | Pharmaceutical composition for nasal delivery of estradiol and norethisterone | |
AU2001287930A1 (en) | Pharmaceutical formulation for pulmonary or nasal administration | |
AU2001284287A1 (en) | Pharmaceutical combination containing salmeterol and fluticasone | |
AU6633101A (en) | Peptide compound and pharmaceutical compositions and medicines containing the same as the active ingredient | |
AU4960299A (en) | Nose airway and drug delivery device |